Figure 6.
Changes of BrdU-staining in blood eosinophils in sensitized and exposed to allergen (OVA; 100 μg intranasally on five consecutive days) Balb/c mice after the treatment with a) anti-IL-9 antibody or its isotype control IgG (100 μg/animal); or with b) anti-IL-5 antibody or its isotype control IgG1 (50 μg/animal) 30 minutes before the first exposure. BrdU was injected on first and third day of OVA exposure period. Data are shown as mean ± SEM (n = 5–10 per group). *p < 0.05 compared with the corresponding isotype control antibody (Mann-Whitney U test).